Topic · page 23 of 26

Spondyloarthritis & psoriatic arthritis

Axial spondyloarthritis (radiographic and non-radiographic), peripheral spondyloarthritis, psoriatic arthritis and psoriatic disease studied across joints and skin, enthesitis and dactylitis, arthritis with inflammatory bowel disease, reactive arthritis, uveitis in spondyloarthritis, imaging of the sacroiliac joints and spine

Briefs 881–920 of 1,039 placed here, newest publication first

Briefs in Spondyloarthritis & psoriatic arthritis

Newest publication first

RMD Open24 Mar 2023
Characterisation of gut microbiota composition in patients with axial spondyloarthritis and its modulation by TNF inhibitor treatment
Cohort study
RMD Open23 Mar 2023
Risk of cancer in Korean patients with psoriatic arthritis: a nationwide population-based cohort study
Cohort study
RMD Open23 Mar 2023
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
Meta-analysis
Joint Bone Spine17 Mar 2023
Differences between early vs. late-onset of psoriatic arthritis: Data from the RESPONDIA and REGISPONSER registries
Cross-sectional study
RMD Open16 Mar 2023
Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment
Cross-sectional study
RMD Open15 Mar 2023
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
Cohort study
Rheumatology (Oxford)15 Mar 2023
Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK)
Randomized controlled trial
Arthritis Care Res (Hoboken)15 Mar 2023
Influence of Sex on Early Axial Spondyloarthritis: A Six‐Year Longitudinal Analysis From a Large National Cohort
Cohort study
RMD Open13 Mar 2023
Good construct validity of the CT Syndesmophyte Score (CTSS) in patients with radiographic axial spondyloarthritis
Diagnostic or prognostic study
Arthritis Res Ther13 Mar 2023
Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry
Cohort study
Rheumatology (Oxford)10 Mar 2023
Association between triglyceride-glucose index and carotid atherosclerosis in patients with psoriatic arthritis
Cross-sectional study
RMD Open10 Mar 2023
Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA
Cohort study
RMD Open9 Mar 2023
High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex
Cross-sectional study
Lancet Rheumatol6 Mar 2023
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study
Cohort study
Clin Exp Rheumatol2 Mar 2023
Anti-TNF-α induced paradoxical psoriasis in patients with ankylosing spondylitis: a systematic review
Meta-analysis
RMD Open2 Mar 2023
Caesarean section in women with axial spondyloarthritis and psoriatic arthritis: a population-based study
Cohort study
J Rheumatol1 Mar 2023
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017
Cross-sectional study
Scand J Rheumatol27 Feb 2023
Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up (Italian arm of the SPondyloArthritis Caught Early (SPACE) study)
Cohort study
RMD Open24 Feb 2023
Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis
Secondary analysis
Clin Exp Rheumatol23 Feb 2023
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study
Randomized controlled trial
Ann Rheum Dis22 Feb 2023
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries
Cohort study
Rheumatology (Oxford)22 Feb 2023
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data
Secondary analysis
Joint Bone Spine15 Feb 2023
Costovertebral joint involvement in patients with axial spondyloarthritis
Cross-sectional study
J Rheumatol15 Feb 2023
Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program
Randomized controlled trial
Ann Rheum Dis14 Feb 2023
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries
Cohort study
Semin Arthritis Rheum14 Feb 2023
The evolving demographics of participants in psoriatic arthritis phase III randomised controlled trials of b/tsDMARDs: A systematic review
Meta-analysis
RMD Open9 Feb 2023
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis
Cohort study
Rheumatology (Oxford)8 Feb 2023
Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study
Cohort study
Clin Exp Rheumatol8 Feb 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs
Cohort study
Clin Exp Rheumatol7 Feb 2023
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia
Cross-sectional study
Rheumatology (Oxford)3 Feb 2023
Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis
Case-control study
J Rheumatol1 Feb 2023
Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials
Diagnostic or prognostic study
RMD Open31 Jan 2023
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study
Randomized controlled trial
Lancet Rheumatol30 Jan 2023
Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: a cohort study
Cohort study
Clin Exp Rheumatol30 Jan 2023
Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain
Diagnostic or prognostic study
Joint Bone Spine25 Jan 2023
Impact of key manifestations of psoriatic arthritis on patient quality of life, functional status, and work productivity: Findings from a real-world study in the United States and Europe
Cross-sectional study
Arthritis Care Res (Hoboken)19 Jan 2023
All‐Cause and Cause‐Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta‐Analysis
Meta-analysis
Ann Rheum Dis17 Jan 2023
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
Randomized controlled trial
RMD Open17 Jan 2023
Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study
Cohort study
Scand J Rheumatol16 Jan 2023
Real-world registry-based study on apremilast use in psoriasis and psoriatic arthritis in Finland
Cohort study

All 1,039 Briefs in ExploreShowing Briefs 881–920 of 1,039, newest first